OVERVIEW

Amid the coronavirus pandemic, the global market size of biopsy devices is expected to grow over the forecast period at a CAGR of 5.7%. Factors such as rising cancer prevalence shifting to minimally invasive surgery, the efforts by government and global health organizations to raise awareness of cancer, and the improved reimbursement scenario across developed country are driving global market development. The report discusses in detail the impact of COVID-19 on market for the year 2020 and beyond.